NeuroSense Cleared to Study PrimeC Food Interactions in Healthy People
NeuroSense Therapeutics will soon begin a Phase 1 clinical trial to investigate the impact of food on PrimeC, a…
Articles by Margarida Maia, PhD
Lab Results Support Advancing QRL-201 to Clinical Trial
An investigational antisense oligonucleotide (ASO) molecule that works by increasing the production of Stathmin-2 protein effectively reversed a number of…
Stem Cell Therapy Safe, Shows Potential to Slow Progression in Trial
Repeat injections of mesenchymal stem cells (MSCs) into the spinal canal were safe and well tolerated in patients with…
TQS-168 Found to Reduce Inflammation, Extend Survival in Mice
TQS-168, an investigational therapy being developed by Tranquis Therapeutics, reduced inflammation in mouse and human models of amyotrophic…
Higher ‘Good’ Cholesterol Levels Appear to Lower Risk of ALS
Certain blood biomarkers of lipid, or fat, metabolism — typically measured to determine a person’s risk of cardiovascular disease —…
Speech Study Using AI Technology to Spot ALS Biomarkers
A technology based on artificial intelligence is helping to spot biomarkers and document the progression of amyotrophic lateral sclerosis…
NIH $1.25M Grant Supports Work Into Nerve Cell Loss in ALS
A Temple University research team received a National Institutes of Health (NIH) grant totaling $1.25 million to explore the molecular…
MLB, National ALS Registry Join in Honoring ‘Lou Gehrig Day’
Today, the National ALS Registry is joining the Major League Baseball to celebrate Lou Gehrig’s life and legacy…
NeuroInsight Grant Going to Award 33 Fellowships to ALS, Other Researchers
A research training program in Ireland, called NeuroInsight Fellowship, will use a multi-million grant award to bring established scientists from…
Phase 2 Study of RT001 in ALS Patients Fully Enrolled, Retrotope Says
A Phase 2 clinical trial evaluating oral RT001 — Retrotope’s experimental synthetic fatty acid — as a treatment…